Global aHUS Registry Analysis of Patients Switching to Ravulizumab from Eculizumab

Schaefer, F., Al-Dakkak, I., Anokhina, K., Cohen, D., Greenbaum, L. A., & Ariceta, G. (2024). Global aHUS Registry Analysis of Patients Switching to Ravulizumab From Eculizumab. Kidney International Reports. https://doi.org/10.1016/j.ekir.2024.06.020
Authors:
Franz Schaefer
Imad Al‐Dakkak
Katerina Anokhina
David J. Cohen
Larry A. Greenbaum
Gema Ariceta
Affiliated Authors:
David J. Cohen
Columbia Affiliation:
Subjects:
Role of Complement System in Immune Response (OpenAlex Topic)
Kidney Transplantation (OpenAlex Topic)
Genetic Basis of Primary Immunodeficiency Disorders (OpenAlex Topic)
Author Keywords:
atypical hemolytic uremic syndrome
eculizumab
outcomes
patient characteristics
ravulizumab
real-world data
elink
Publication Type:
Article
Unique ID:
10.1016/j.ekir.2024.06.020
DOI:
10.1016/j.ekir.2024.06.020
Journal:
Kidney International Reports
Publication Date:
Data Source:
OpenAlex
Source Link:
View OpenAlex Record
View PubMed Record
View Scopus Record
View Web of Science Record

Record Created: